OakChart

Vyome Holdings Inc

HINDHealthcare·Biotechnology·USA·Nano·NASD·Nov 11 • 3:58 PM ET

1.57+0.03 (1.95%)
2026-11-12 06:03 CET
Market cap
11.02 USD m
Revenue, TTM
0.13 USD m
Net income, TTM
-11.31 USD m
Free cash flow, TTM
0.52 USD m
EPS diluted, TTM
-3.51
P/E
-
Compare

Price

HIND against its 20, 50 and 200-day averages
2050200beatearnings
2.003.004.005.00127K254KVolumeMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26HINDclose 1.5720-day 1.7450-day 1.91200-day 2.191.57

73.3% under the 52-week high of 5.88 on 8 Dec 2025. 52-week low 1.53 on 10 Nov 2026. Last 15 sessions, 40.0% high to low

Volume 0.85× normal · the line is the 50-bar volume average

Profile

HIND
52-week range, 1% of the way up
1.535.88

Vyome Holdings, Inc. engages in the development of immuno-inflammatory assets. It focuses on therapeutic solutions that target formulations for site-targeted applications. The company was founded on January 2, 2008 and is headquartered in Cambridge, MA.

Employees18
IPOOct 06, 2016
Beta1.49
ATR, 14d0.11
Rel volume0.85
Short float0.56%
Insider own52.82%
Inst own2.02%

Snapshot

6 groups

Valuation

Index-
Market Cap11.02M
Enterprise Value4.41M
Income-11.31M
Sales0.13M
Book/sh0.86
Cash/sh1.12
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout-
Employees18
IPOOct 06, 2016

Ratios

P/E-
Forward P/E-
PEG-
P/S84.77
P/B1.82
P/C1.40
P/FCF21.19
EV/EBITDA-
EV/Sales33.93
Quick Ratio4.37
Current Ratio4.37
Debt/Eq0.00
LT Debt/Eq0.00
Option/ShortNo / Yes

Earnings

EPS (ttm)-3.51
EPS next Y-0.84
EPS next Q-0.20
EPS this Y86.47%
EPS next Y-29.74%
EPS next 5Y45.10%
EPS past 3/5Y98.04% 93.71%
Sales past 3/5Y-69.47% -50.98%
EPS Y/Y TTM99.28%
Sales Y/Y TTM-97.99%
EPS Q/Q98.91%
Sales Q/Q-97.83%
EarningsAug 25 BMO
EPS/Sales Surpr.47.37% -

Ownership

Insider Own52.82%
Insider Trans0.00%
Inst Own2.02%
Inst Trans1.96%
ROA-124.23%
ROE-190.41%
ROIC-186.95%
Gross Margin44.49%
Oper. Margin-3250.25%
Profit Margin-8716.77%
SMA20-9.63%
SMA50-17.91%
SMA200-28.36%
Trades-

Technical

Shs Outstand7.02M
Shs Float3.31M
Short Float0.56%
Short Ratio1.34
Short Interest0.02M
52W High5.88 -73.30%
52W Low1.53 2.71%
Volatility7.29% 6.01%
ATR (14)0.11
RSI (14)29.59
Beta1.49
Rel Volume0.85
Avg Volume13.80K
Volume11,784

Performance

Perf Week-9.56%
Perf Month-20.30%
Perf Quarter-27.31%
Perf Half Y-18.23%
Perf YTD-54.36%
Perf Year-70.43%
Perf 3Y-99.89%
Perf 5Y-100.00%
Perf 10Y-100.00%
Recom1.00
Target Price8.83
Prev Close1.54
Price1.57
Change %1.95%

Analyst ratings

latest 1 of 1
DateActionAnalystRating changeTargetImplied
Sep 03, 2026InitiatedCChardan Capital MarketsBuy$3.50+122.9%

Peers

Mkt cap
TickerCompanyMkt cap
KPRXKiora Pharmaceuticals Inc5.98M
OKYOOKYO Pharma Limited74.52M
KALAKala Bio Inc3.31M
ALDXAldeyra Therapeutics Inc39.32M
AZTRAzitra Inc3.55M
DRMADermata Therapeutics Inc3.54M
QNRXQuoin Pharmaceuticals Ltd ADR18.05M
EDSAEdesa Biotech Inc29.99M
VRCAVerrica Pharmaceuticals Inc67.17M
ACRSAclaris Therapeutics Inc688.38M

Held by

AUM
TickerCompanyAUM
VXFVanguard Extended Market Index ETFAUM: 30.47B

News

latest 14 of 58

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q22026-08-25-0.100-0.190-0.1000.03-1
2026Q12026-05-28-0.150-0.150-0.1500.03-1
2025Q42026-03-26-0.470-0.470-0.2070.25-1
2025Q32025-11-18-3.120-0.110-3.0570.25-1
2025Q22025-08-18-0.070--9.0010.25--
2025Q12025-05-2178.083-75.9131.11--
2024Q32024-11-14---2.30--
2024Q22024-08-14---1.97--
2024Q12024-05-20---1.94--
2023Q32023-11-08---2.16--
2023Q22023-08-07---2.25--
2023Q12023-05-15---2.29--
2022Q32022-11-14---2.80--
2022Q22022-08-15---2.89--
2022Q12022-05-23---0.4402.44--
2021Q32021-11-12---1.4803.71--

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2024FY-1,421--24.4538.01-
2025FY-4.805-4.750-4.8050.32-
2026FY--0.650--0.07
2027FY--0.843--0.25
2028FY--0.795--0.00
2029FY--0.105--13.49
2030FY-1.130--44.23

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q3S2026-09-021000.000.000.00
2026Q3R2026-10-01101-0.23-0.23-0.23
2026Q3R2026-08-25100-0.21-0.21-0.21
2026Q3R2026-08-02100-0.21-0.21-0.21
2026Q3R2026-05-28101-0.21-0.21-0.21
2026Q3R2026-05-19101-0.21-0.21-0.21
2026Q3R2026-03-26110-0.20-0.20-0.20
2026Q3R2026-03-24110-0.20-0.20-0.20
2026Q3R2026-02-01100-0.21-0.21-0.21
2026Q3R2025-11-18101-0.21-0.21-0.21
2026Q3R2025-11-12100-0.12-0.12-0.12
2026Q3R2025-11-11100-0.12-0.12-0.12
2026Q3R2025-11-10100-0.12-0.12-0.12
2026Q3R2025-11-09100-0.12-0.12-0.12

Estimate history

EPS, annual-18096000.116-17083146.109-4376274.028-4819269.331-1676017.301-631591.696-11087.744-24.453-4.748-3.506
Period201720182019202020212022202320242025TTM
EPS, quarterly-366.792-310.7-241.23975.913-9.001-3.057-0.207-0.144-0.098
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Sales, annual9.9149.1013.28111.29913.611.248.6780.2570.320.13
Period201720182019202020212022202320242025TTM
Sales, quarterly1.9652.2921.8051.1131.2420.0350.0370.0320.027
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Shares, annual0000000.0040.0595.9197.019
Period201720182019202020212022202320242025MRQ
Shares, quarterly0.0050.0070.0070.0330.6565.5565.9197.0197.019
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue0.130.320.268.6811.2413.6011.303.289.10
Cost of Goods Sold Incl. D&A0.070.110.083.134.445.255.042.905.42
Gross Profit0.060.210.185.556.808.356.260.383.68
Selling, General and Administrative Excl. Other4.272.951.1820.1933.8833.2818.7222.5240.64
Research and Development1.590.590.292.312.542.373.506.5210.70
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income-4.22-2.75-1.01-14.64-27.08-24.93-12.46-22.13-36.97
Interest Expense0.040.150.21-0.110.832.050.390.23
Unusual Expense7.717.680.24-3.1018.7437.827.711.10-
Net Income Before Taxes-11.58-10.48-1.45-11.34-46.59-63.42-21.81-23.68-37.38
Income Taxes0.000.000.000.05-0.38-0.27-0.180.000.00
Consolidated Net Income-11.58-10.48-1.45-11.39-46.21-63.15-21.63-23.68-37.38
Net Income From Continuing Operations-11.31-10.26-1.45-11.39-46.21-63.15-21.63-23.68-37.38
Net Income-11.31-10.26-1.45-11.39-46.21-63.15-21.63-23.68-37.38
EPS (Recurring)-0.84-2.26-21.63-13,201.38-452,273.99-973,290.65-3,616,011.70-4,234,073.04-17,083,114.28
EPS (Basic, Before Extraordinaries)-3.51-4.75-24.45-11,087.74-631,591.70-1,676,017.30-4,819,269.33-4,376,274.03-17,083,146.11
EPS (Diluted)-3.51-4.75-24.45-11,087.74-631,591.70-1,676,017.30-4,819,269.33-4,376,274.03-17,083,146.11
EBITDA-4.21-2.74-0.99-14.48-24.93-22.96-10.79-21.24-36.38
Non-Operating Income (Expense)0.380.090.000.20-0.660.170.41-0.06-0.19
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense0.470.580.000.611.658.930.972.983.71
Price To Sales Ratio116.3223.26102.750.170.251.320.522.734.33
Gross Margin44.4964.6869.1363.9360.5261.3855.4211.7040.41
Operating Margin-3,250.25-859.22-391.66-168.69-240.91-183.33-110.25-674.52-406.16
Net Margin-8,716.77-3,209.75-563.34-131.22-411.16-464.31-191.43-721.61-410.72
Shares Outstanding7.025.920.060.000.000.000.000.000.00
Market Capitalization11.0211.023.260.863.0529.2411.6614.6848.67

Income statement, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q12024Q42024Q3
Total Revenue0.030.030.040.031.241.111.802.29
Cost of Goods Sold Incl. D&A0.020.020.020.020.640.430.490.85
Gross Profit0.010.010.020.020.600.681.321.44
Selling, General and Administrative Excl. Other0.871.141.370.882.652.521.963.20
Research and Development0.510.670.380.040.480.360.520.40
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income-0.86-1.13-1.36-0.87-2.05-1.84-0.64-1.76
Interest Expense0.000.000.010.03-0.04-0.00
Unusual Expense0.000.000.007.710.71-3.321.05-0.03
Net Income Before Taxes-0.72-0.99-1.28-8.60-2.621.48-1.76-1.57
Income Taxes0.000.000.000.000.010.010.010.01
Consolidated Net Income-0.72-0.99-1.28-8.60-2.631.47-1.76-1.58
Net Income From Continuing Operations-0.69-0.96-1.23-8.43-2.631.47-1.76-1.58
Net Income-0.69-0.96-1.23-8.43-2.631.47-1.76-1.58
EPS (Recurring)-0.10-0.14-0.21-1.10-7.30-43.70-140.17-314.41
EPS (Basic, Before Extraordinaries)-0.10-0.14-0.21-3.06-9.0075.91-241.24-310.70
EPS (Diluted)-0.10-0.14-0.21-3.06-9.0075.91-241.24-310.70
EBITDA-0.86-1.13-1.35-0.87-2.05-1.83-0.64-1.75
Non-Operating Income (Expense)0.150.150.090.000.140.04-0.060.16
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense0.010.000.000.450.010.010.010.03
Price To Earnings Ratio-0.03------
Price To Sales Ratio116.3210.708.393.410.440.100.410.35
Gross Margin33.5744.4453.0244.0248.2361.1973.0762.78
Operating Margin-3,200.02-3,576.78-3,707.35-2,508.96-165.14-165.23-35.57-76.83
Net Margin-2,543.34-3,048.05-3,352.75-24,356.17-211.76132.43-97.56-68.98
Shares Outstanding7.027.025.925.560.660.030.010.01
Market Capitalization11.0215.0919.423.496.401.203.263.98

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments4.980.104.563.9622.823.0114.0523.7344.40
Short Term Receivables0.100.051.662.182.812.620.280.884.31
Inventories0.000.003.743.613.002.241.941.581.42
Other Current Assets0.360.040.340.171.301.071.962.451.63
Total Current Assets5.440.1910.309.9129.948.9418.2328.6551.76
Net Property, Plant & Equipment0.080.120.310.871.721.052.161.741.35
Total Investments and Advances0.000.000.000.000.000.000.000.000.00
Long-Term Note Receivable0.600.65-------
Intangible Assets0.310.310.000.2620.8327.020.000.000.00
Deferred Tax Assets-0.060.090.180.372.65---
Other Assets0.070.110.030.050.050.050.000.000.00
Total Assets6.501.3810.7311.2752.9139.7120.3930.3953.10
Short Term Debt Incl. Current Port. of LT Debt0.033.620.110.170.283.920.569.931.96
Accounts Payable0.650.501.691.933.473.650.651.161.28
Income Tax Payable-0.030.060.120.330.27---
Other Current Liabilities2.061.621.925.263.463.762.776.146.78
Total Current Liabilities2.745.743.787.487.5311.613.9817.2310.01
Long Term Debt0.000.030.150.000.009.330.570.007.96
Provision for Risks Charges0.000.000.000.000.301.020.000.000.00
Deferred Tax Liabilities-0.040.060.120.743.27---
Other Liabilities0.000.000.070.000.000.000.000.050.01
Total Liabilities2.745.774.067.608.5725.234.5417.2817.99
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.003E-060.000.000.000.000.000.000.00
Common Equity2.44-4.396.663.6644.3314.4915.8513.1135.11
Total Shareholders Equity2.44-4.396.663.6644.3314.4915.8513.1135.11
Accumulated Minority Interest1.321E-060.000.000.000.000.000.000.00
Total Equity3.76-4.396.663.6644.3314.4915.8513.1135.11
Total Liabilities & Stockholders Equity6.501.3810.7311.2752.9139.7120.3930.3953.10
Book Value Per Share0.41-74.181,647.5040,895.65720,997.313,615,253.991,785,143.914,849,635.7217,455,574.79
Tangible Book Value Per Share0.36-79.491,647.5037,991.29382,290.88-3,128,129.281,785,143.914,849,635.7217,455,574.79
Full-Time Employees1818314047234103137
Price to Book Ratio1.82-12.870.280.150.632.500.933.712.64
Return on Assets-181.22-23.91-103.56-140.71-136.36-71.97-93.25-89.55-52.72
Return on Equity-937.57-127.42-220.59-185.85-214.70-142.60-163.53-155.04-69.94
Return on Invested Capital-420.22--167.11-1,262.33-142.43-90.81-144.23-285.19-80.70
Quick Ratio1.990.031.740.843.580.584.101.575.03
Current Ratio1.990.032.731.323.980.774.591.665.17

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income-11.03-10.48-1.45-11.39-46.21-63.15-21.63-23.68-37.38
Depreciation0.010.010.020.152.151.971.670.890.58
Other Funds (Non Cash)10.466.680.43-1.6221.8748.7611.493.184.79
Funds from Operations-0.55-3.79-1.00-12.83-22.61-12.66-8.56-19.60-32.01
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital1.070.040.39-4.130.71-2.710.01-3.262.58
Cash from Operating Activities0.52-3.75-0.61-16.96-21.90-15.38-8.55-22.87-29.43
Capital Expenditures0.000.000.00-0.04-0.13-0.35-0.39-0.19-1.28
Net Assets From Acquisitions0.000.000.000.000.002.21-2.000.00-
Sale of Fixed Assets and Businesses0.000.000.000.030.040.000.000.00-
Purchase or Sale of Investments0.000.000.000.000.000.000.002.5520.80
Purchase of Investments0.000.000.000.000.000.000.000.00-9.10
Sale Or Maturity of Investments0.000.000.000.000.000.000.002.5529.90
Other Uses0.000.000.000.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.000.000.000.00
Cash from Investing Activities0.000.000.00-0.01-0.091.85-2.392.3619.52
Cash Dividends Paid0.000.000.000.000.000.000.000.000.00
Change in Capital Stock2.297.860.0017.573.1342.800.6823.3810.02
Repurchase of Common Pref Stock0.000.000.000.000.000.000.000.000.00
Sale of Common Pref Stock2.297.860.0017.573.1342.800.6823.3810.02
Proceedsfrom Stock Options2.287.860.0013.440.00-3.230.0023.389.97
Issuance or Reduction of Debt, Net1.600.790.670.000.00-9.5010.40-10.000.00
Change in Long Term Debt0.000.000.000.000.00-9.5010.40-10.000.00
Issuance of Long Term Debt0.000.000.000.000.001.0010.4010.000.00
Reduction of Long Term Debt0.000.000.000.000.00-10.500.00-20.000.00
Net Financing Active Other Cash Flow0.000.000.030.000.000.000.000.00-0.03
Other Financing Activities Uses0.000.000.000.000.000.000.000.00-0.03
Cash from Financing Activities3.898.650.7017.573.1333.3011.0713.389.99
Exchange Rate Effect-0.06-0.030.000.000.000.03-0.11--
Net Change in Cash4.364.880.090.60-18.8619.810.02-7.130.08
Free Cash Flow0.52-3.75-4.52-17.00-22.03-15.73-8.94-23.06-30.71
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.000.00
Price to Free Cash Flow28.77--------
Deferred Taxes & Investment Tax Credit-0.000.000.03-0.42-0.25-0.090.000.00

Balance sheet, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q1
Cash & Short Term Investments7.898.804.985.714.222.62
Short Term Receivables0.150.140.100.091.380.73
Inventories0.000.000.000.002.552.53
Other Current Assets0.110.230.360.240.710.41
Total Current Assets8.159.165.446.048.866.29
Net Property, Plant & Equipment0.060.070.080.090.110.13
Total Investments and Advances0.000.000.000.000.000.00
Intangible Assets0.310.310.310.31--
Deferred Tax Assets----0.030.03
Other Assets0.650.640.070.610.030.03
Total Assets9.1810.196.507.059.036.48
Short Term Debt Incl. Current Port. of LT Debt0.020.020.030.030.100.12
Accounts Payable0.550.530.651.651.351.69
Income Tax Payable-----0.010.21
Other Current Liabilities1.301.592.061.431.752.11
Total Current Liabilities1.862.142.743.123.204.12
Long Term Debt0.000.000.000.010.000.01
Provision for Risks Charges0.000.000.000.000.000.00
Other Liabilities0.000.000.000.000.001.12
Total Liabilities1.862.142.743.133.205.25
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity6.056.742.442.535.831.23
Total Shareholders Equity6.056.742.442.535.831.23
Accumulated Minority Interest1.261.301.321.390.000.00
Total Equity7.318.043.763.925.831.23
Total Liabilities & Stockholders Equity9.1810.196.507.059.036.48
Book Value Per Share0.860.960.410.468.8936.97
Tangible Book Value Per Share0.820.920.360.408.8936.97
Full-Time Employees--18---
Price to Book Ratio1.825.217.560.581.100.98
Return on Assets-124.23-159.01-191.00-179.31-58.34-47.07
Return on Equity-190.41-332.39-988.12-565.18-101.49-120.16
Return on Invested Capital-11.33-14.28-50.18-332.32-45.12118.49
Quick Ratio4.374.271.991.941.970.91
Current Ratio4.374.271.991.942.771.53

Cash flow, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q1
Net Income-0.72-0.99-1.28-8.04-2.631.47
Depreciation0.000.000.000.000.000.00
Other Funds (Non Cash)0.010.040.1010.310.01-3.75
Funds from Operations-0.71-0.95-1.172.28-2.62-2.27
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital-0.20-0.49-0.302.06-1.870.16
Cash from Operating Activities-0.90-1.44-1.484.34-4.49-2.12
Capital Expenditures0.000.000.000.000.000.00
Net Assets From Acquisitions0.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.00
Purchase or Sale of Investments0.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.00
Other Uses0.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.00
Cash from Investing Activities0.000.000.000.000.000.00
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock-0.005.29-0.10-2.906.104.76
Repurchase of Common Pref Stock0.000.000.000.000.000.00
Sale of Common Pref Stock-0.005.29-0.10-2.906.104.76
Proceedsfrom Stock Options-0.005.29-0.10-2.906.104.76
Issuance or Reduction of Debt, Net0.000.000.601.000.00-0.81
Change in Long Term Debt0.000.000.000.000.000.00
Issuance of Long Term Debt0.000.000.000.000.000.00
Reduction of Long Term Debt0.000.000.000.000.000.00
Net Financing Active Other Cash Flow0.000.000.26-0.260.000.00
Other Financing Activities Uses0.000.000.26-0.260.000.00
Cash from Financing Activities-0.005.290.76-2.166.103.95
Exchange Rate Effect-0.00-0.04-0.01-0.010.00-0.01
Net Change in Cash-0.913.81-0.722.181.611.82
Free Cash Flow-0.90-1.44-1.484.34-4.49-2.12
Price to Free Cash Flow28.77-----

Revenue breakdown

License2025: 116.90K
Product2024: 134.40K 2025: 174.65K
Royalty2024: 47.40K 2025: 28.17K
Service2024: 75.15K
United States2024: 256.94K 2025: 319.71K

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-300.56%0.0M3.3M13.33K
2026-10-150.62%0.0M3.3M12.78K
2026-09-300.79%0.0M3.3M14.02K
2026-09-150.65%0.0M3.3M12.12K
2026-08-310.58%0.0M3.3M14.47K
2026-08-140.74%0.0M3.3M17.37K
2026-07-310.83%0.0M3.3M24.37K
2026-07-151.17%0.0M3.3M27.11K
2026-06-301.06%0.0M3.3M26.77K
2026-06-151.96%0.1M3.3M28.83K
2026-05-292.35%0.1M3.3M33.56K
2026-05-153.72%0.1M3.3M48.98K
2026-04-303.67%0.1M3.3M110.88K
2026-04-157.49%0.1M1.9M869.72K
2026-03-318.25%0.2M1.9M871.33K
2026-03-136.69%0.1M1.9M870.30K
2026-02-2713.43%0.2M1.6M864.84K
2026-02-1312.20%0.2M1.6M848.30K
2026-01-3016.82%0.3M1.6M785.93K
2026-01-155.24%0.1M1.6M43.93K

Option chain

expiry 2026-11-12
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
No option chain for this symbol.

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-09-034Statement of changes in beneficial ownership of securities2026-09-01SEC
2026-09-013Initial statement of beneficial ownership of securities2026-09-01SEC
2026-08-288-KCurrent report2026-08-25SEC
2026-08-258-KCurrent report2026-08-25SEC
2026-08-1210-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-05-298-KCurrent report2026-05-28SEC
2026-05-1210-QQuarterly report pursuant to Section 13 or 15(d)2026-03-31SEC
2026-04-298-KCurrent report2026-04-24SEC
2026-03-31DEF 14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 19342026-04-24SEC
2026-03-20PRE 14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 19342026-03-20SEC
2026-03-1810-KAnnual report pursuant to Section 13 or 15(d)2025-12-31SEC
2026-02-258-KCurrent report2026-02-20SEC
2026-02-138-KCurrent report2026-02-13SEC
2026-01-288-KCurrent report2026-01-28SEC
2025-12-238-KCurrent report2025-12-17SEC
2025-11-26424B3SEC
2025-11-198-KCurrent report2025-11-18SEC
2025-11-194Statement of changes in beneficial ownership of securities2025-11-13SEC
2025-11-193Initial statement of beneficial ownership of securities2025-08-15SEC
2025-11-184Statement of changes in beneficial ownership of securities2025-08-15SEC
2025-11-183Initial statement of beneficial ownership of securities2025-08-15SEC
2025-11-174Statement of changes in beneficial ownership of securities2025-11-13SEC
2025-11-174Statement of changes in beneficial ownership of securities2025-11-13SEC
2025-11-173Initial statement of beneficial ownership of securities2025-08-15SEC
2025-11-174Statement of changes in beneficial ownership of securities2025-11-13SEC
2025-11-1410-QQuarterly report pursuant to Section 13 or 15(d)2025-09-30SEC
2025-11-13S-8Initial registration statement for securities to be offered to employees pursuant to employee benefit plansSEC
2025-11-06S-3Registration statement for specified transactions by certain issuers including face-amount certificate companiesSEC
2025-10-308-KCurrent report2025-10-28SEC
2025-10-06DEF 14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 19342025-10-28SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-080000
2026-070000
2026-060000
2026-050000
2026-040000
2026-030000
2026-020000
2026-010000
2025-120000
2025-110000

Institutional holders

Manager% owned
CITADEL ADVISORS LLC0.37%
GEODE CAPITAL MANAGEMENT, LLC0.36%
HRT FINANCIAL LP0.29%
Focus Partners Wealth0.21%
VANGUARD FIDUCIARY TRUST CO0.17%
SUSQUEHANNA INTERNATIONAL GROUP, LLP0.14%
VANGUARD CAPITAL MANAGEMENT LLC0.13%
ROYAL BANK OF CANADA0.08%
UBS Group AG0.04%
Tower Research Capital LLC0.03%

Funds

Fund% owned
Fidelity Extended Market Index Fund0.23%
VANGUARD EXTENDED MARKET INDEX FUND0.13%
Fidelity Series Total Market Index Fund0.05%
Blackstone Alternative Multi-Strategy Fund-0.01%

OakChart. HIND. Cached 15 minutes.

Some panels did not load: insider.